Lagerstandorte

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

873950-18-6Atorvastatin FX1 Impurity

● Auf Lager

Katalog-Nr.::	VE008426
CAS-Nr.::	873950-18-6
Summenformel::	C33H35FN2O7
Molare Masse::	590.64 g/mol

Angebot anfordern

Zur RFQ-Liste hinzufügen

Zusätzliche Informationen zu CAS 873950-18-6

Parent drug

Atorvastatin

IUPAC-Name

1b-(4-Fluorophenyl)hexahydro-β, 7-dihydroxy-7-(1-methylethyl)-1a-phenyl-7a-[(phenylamino)carbonyl]-3H-oxireno[3, 4]pyrrolo[2, 1-b][1, 3]oxazine-3-butanoic acid

Pharmakopöe-Synonyme

Atorvastatin Epoxy Pyrrolooxazin 7-Hydroxy Analog

Other Synonyms

Atorvastatin Degradation Product – ATV-FX1; Atorvastatin Cyclic Fluorophenyl Impurity; 4-(1B-(4-fluorophenyl)-7-hydroxy-7-isopropyl-1a-phenyl-7a-(phenylcarbamoyl)hexahydro-3H-oxireno[2′,3′:3,4]pyrrolo[2,1-b][1,3]oxazin-3-yl)-3-hydroxybutanoic acid

SMILES

CC(C)C1(C2(C(O2)(C3(N1CCC(O3)CC(CC(=O)O)O)C4=CC=C(C=C4)F)C5=CC=CC=C5)C(=O)NC6=CC=CC=C6)O

InChI

InChI=1S/C33H35FN2O7/c1-21(2)32(41)31(29(40)35-25-11-7-4-8-12-25)30(43-31,22-9-5-3-6-10-22)33(23-13-15-24(34)16-14-23)36(32)18-17-27(42-33)19-26(37)20-28(38)39/h3-16,21,26-27,37,41H,17-20H2,1-2H3,(H,35,40)(H,38,39)

Shipping Condition

Ambient Temperature

Characterization Data (Included)

HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, and Structure Elucidation Report (SER).

Additional Characterization Data

QNMR, D2O Exchange, 13C NMR, 13C APT, COSY NMR, NOESY NMR, 15N NMR, HSQC NMR, HMQC NMR, and HMBC NMR. These are available upon request and may be free or subject to additional charges.

Beschreibung

Atorvastatin FX1 Impurity known in pharmacopoeias as Atorvastatin Epoxy Pyrrolooxazin 7-Hydroxy Analog is a thoroughly characterized reference standard. It meets strict regulatory standards including those set by USP EMA JP and BP. This product is crucial for use in Abbreviated New Drug Applications (ANDA) New Drug Applications (NDA) and the commercial production of Atorvastatin. Additionally it comes with a detailed Structure Elucidation Report (SER) ensuring its precision and dependability for a variety of analytical uses. It is an impurity of Atorvastatin with CAS (Chemical Abstract Service number) 873950-18-6. Its name in United States Pharmacopeia is Atorvastatin Epoxy Pyrrolooxazin 7-Hydroxy Analog.